Acetyldigitoxin
Acetyldigitoxin
|
Systematic (IUPAC) name |
---|
[(2R,3R,4S,6S)-3-Hydroxy-6-[(2R,4S,6S)-4-hydroxy-6-[(2R,3S,4S,6R)-4-hydroxy-6-[ [(5R,8R,9S,10S,13R,14S,17R')-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyloxan-4-yl] acetate |
Clinical data |
---|
Identifiers |
---|
|
1111-39-3 N |
---|
|
C01AA01 |
---|
PubChem |
CID 68949 |
---|
DrugBank |
DB00511 Y |
---|
ChemSpider |
4447572 Y |
---|
UNII |
0ZV4Q4L2FU Y |
---|
KEGG |
D06881 Y |
---|
ChEBI |
CHEBI:53773 Y |
---|
ChEMBL |
CHEMBL1200634 N |
---|
Chemical data |
---|
Formula |
C43H66O14 |
---|
|
806.976 g/mol |
---|
SMILES
- O=C\1OC/C(=C/1)[C@H]2CC[C@@]8(O)[C@]2(C)CC[C@H]7[C@H]8CC[C@H]6[C@]7(C)CC[C@H](O[C@@H]5O[C@@H]([C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC(=O)C)C3)[C@@H](O)C4)C)[C@@H](O)C5)C)C6
|
InChI=1S/C43H66O14/c1-21-38(48)33(54-24(4)44)19-37(51-21)57-40-23(3)53-36(18-32(40)46)56-39-22(2)52-35(17-31(39)45)55-27-9-12-41(5)26(16-27)7-8-30-29(41)10-13-42(6)28(11-14-43(30,42)49)25-15-34(47)50-20-25/h15,21-23,26-33,35-40,45-46,48-49H,7-14,16-20H2,1-6H3/t21-,22-,23-,26-,27+,28-,29+,30-,31+,32+,33+,35+,36+,37+,38-,39-,40-,41+,42-,43+/m1/s1
Y
Key:HPMZBILYSWLILX-UMDUKNJSSA-N
Y
|
N (what is this?) (verify) |
---|
Acetyldigitoxin is a cardiac glycoside. It is an acetyl derivative of digitoxin.
|
---|
| Bufadienolides | |
---|
| Cardenolides | |
---|
| | | Index of the heart |
---|
| Description |
- Anatomy
- Physiology
- Development
|
---|
| Disease |
- Injury
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
- Blood tests
|
---|
| Treatment |
- Procedures
- Drugs
- glycosides
- other stimulants
- antiarrhythmics
- vasodilators
|
---|
|
|